Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:14PM ET
26.47
Dollar change
+0.69
Percentage change
2.68
%
IndexRUT P/E6.91 EPS (ttm)3.83 Insider Own17.27% Shs Outstand14.68M Perf Week0.46%
Market Cap388.58M Forward P/E6.62 EPS next Y4.00 Insider Trans0.00% Shs Float12.15M Perf Month0.59%
Income54.34M PEG0.86 EPS next Q1.07 Inst Own36.24% Short Float0.67% Perf Quarter-15.02%
Sales263.33M P/S1.48 EPS this Y4.99% Inst Trans0.62% Short Ratio3.28 Perf Half Y15.59%
Book/sh28.96 P/B0.91 EPS next Y0.00% ROA1.29% Short Interest0.08M Perf Year23.69%
Cash/sh- P/C- EPS next 5Y8.00% ROE13.90% 52W Range17.06 - 31.49 Perf YTD-13.75%
Dividend Est.0.80 (3.02%) P/FCF5.84 EPS past 5Y11.04% ROI9.50% 52W High-15.94% Beta0.39
Dividend TTM0.86 (3.25%) Quick Ratio- Sales past 5Y19.74% Gross Margin- 52W Low55.16% ATR (14)0.64
Dividend Ex-DateMar 14, 2024 Current Ratio0.02 EPS Y/Y TTM-6.25% Oper. Margin29.18% RSI (14)51.50 Volatility2.01% 2.11%
Employees496 Debt/Eq0.99 Sales Y/Y TTM49.02% Profit Margin20.63% Recom3.00 Target Price30.00
Option/ShortYes / Yes LT Debt/Eq0.30 EPS Q/Q-3.91% Payout22.03% Rel Volume0.77 Prev Close25.78
Sales Surprise0.20% EPS Surprise0.91% Sales Q/Q37.60% EarningsJan 25 BMO Avg Volume24.99K Price26.47
SMA201.17% SMA50-2.78% SMA2007.63% Trades Volume14,246 Change2.68%
Date Action Analyst Rating Change Price Target Change
Jul-30-21Upgrade Piper Sandler Neutral → Overweight $25 → $26
Sep-25-17Downgrade Sandler O'Neill Buy → Hold
Nov-27-07Downgrade Janney Mntgmy Scott Buy → Neutral
Feb-23-24 09:00AM
Jan-26-24 08:00AM
Jan-25-24 12:34PM
10:47AM
06:21AM
06:00AM Loading…
06:00AM
Dec-06-23 02:07PM
Dec-05-23 09:40AM
Nov-28-23 03:41PM
Oct-27-23 02:52PM
07:30AM
Oct-26-23 06:10AM
06:00AM
Oct-02-23 12:00PM
10:00AM
01:01AM Loading…
Sep-15-23 01:01AM
Sep-08-23 07:10PM
Sep-06-23 10:01AM
Aug-31-23 08:35AM
03:20AM
Aug-30-23 06:06PM
09:40AM
Aug-28-23 12:42PM
Aug-25-23 04:00PM
03:20PM
Aug-24-23 09:38PM
04:45PM
Aug-06-23 08:22AM
Jul-27-23 06:18AM
06:00AM
09:28AM Loading…
Jul-02-23 09:28AM
Jun-09-23 06:08AM
May-25-23 03:45PM
May-21-23 01:37PM
May-12-23 11:00AM
May-05-23 06:58AM
May-04-23 06:29AM
May-03-23 06:46AM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 06:47AM
06:08AM
06:00AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 06:44AM
Apr-09-23 08:24AM
Apr-07-23 07:44AM
Apr-06-23 07:20AM
Apr-05-23 06:11AM
Apr-04-23 07:08AM
Apr-03-23 06:48AM
06:00AM
Mar-31-23 06:36AM
Mar-30-23 06:36AM
Mar-29-23 06:32AM
Mar-28-23 06:46AM
Mar-24-23 06:42AM
Mar-23-23 07:01AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
05:14AM
Feb-24-23 01:16PM
07:17AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-06-23 05:19AM
Jan-27-23 08:28AM
Jan-26-23 07:25AM
06:00AM
Jan-23-23 06:27AM
Dec-12-22 09:57AM
Dec-09-22 07:51AM
Nov-30-22 01:47PM
Nov-17-22 04:40PM
Summit Financial Group, Inc. is a holding company, which engages in the provision of community banking and insurance services. The company was founded on March 5, 1987 and is headquartered in Moorefield, WV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HINKLE GARY LDirectorSep 14 '23Buy24.073,36781,044424,055Sep 14 11:51 AM
HINKLE GARY LDirectorSep 13 '23Buy24.2010,710259,182420,688Sep 14 11:51 AM
HINKLE GARY LDirectorSep 12 '23Buy24.171242,997409,978Sep 14 11:51 AM
Upson Jill SDirectorAug 29 '23Buy24.811,85045,8952,207Aug 30 11:05 AM
JENNINGS SCOTT CEVP & COOMay 04 '23Buy18.171,00018,16814,595May 05 10:42 AM
BEAN OSCAR MChairman of the BoardMay 02 '23Buy18.552424,49083,334May 02 02:42 PM
Hager JosephEVP & Chief Risk OfficerMay 01 '23Buy19.623,00058,8603,000May 01 04:41 PM
Last Close
Mar 28 02:09PM ET
2.20
Dollar change
-0.02
Percentage change
-0.90
%
BEAT HeartBeam Inc monthly Stock Chart
Index- P/E- EPS (ttm)-0.94 Insider Own25.98% Shs Outstand26.33M Perf Week-4.76%
Market Cap57.93M Forward P/E- EPS next Y-0.59 Insider Trans-0.22% Shs Float19.49M Perf Month51.72%
Income-14.64M PEG- EPS next Q-0.14 Inst Own11.79% Short Float0.68% Perf Quarter-3.08%
Sales0.00M P/S- EPS this Y9.72% Inst Trans-3.60% Short Ratio0.75 Perf Half Y5.26%
Book/sh0.61 P/B3.63 EPS next Y9.23% ROA-138.30% Short Interest0.13M Perf Year0.00%
Cash/sh0.61 P/C3.58 EPS next 5Y- ROE-159.89% 52W Range1.06 - 3.74 Perf YTD-6.38%
Dividend Est.- P/FCF- EPS past 5Y-82.01% ROI-91.86% 52W High-41.18% Beta-1.22
Dividend TTM- Quick Ratio14.09 Sales past 5Y0.00% Gross Margin- 52W Low107.55% ATR (14)0.20
Dividend Ex-Date- Current Ratio14.09 EPS Y/Y TTM41.18% Oper. Margin0.00% RSI (14)57.15 Volatility10.22% 12.58%
Employees15 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.78
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q68.21% Payout- Rel Volume0.18 Prev Close2.22
Sales Surprise- EPS Surprise156.77% Sales Q/Q- EarningsMar 20 AMC Avg Volume175.29K Price2.20
SMA206.18% SMA5018.37% SMA2009.25% Trades Volume23,086 Change-0.90%
Mar-20-24 08:53PM
04:05PM
Mar-14-24 08:31AM
Mar-07-24 08:31AM
Mar-05-24 08:31AM
09:00AM Loading…
Jan-31-24 09:00AM
Dec-14-23 08:31AM
Nov-15-23 02:30PM
Nov-14-23 04:01PM
Nov-09-23 08:31AM
Nov-07-23 08:31AM
Oct-31-23 08:31AM
Sep-27-23 08:05AM
Sep-26-23 08:31AM
Sep-21-23 09:35AM
06:17AM Loading…
Aug-15-23 06:17AM
Aug-11-23 01:43PM
Aug-10-23 04:01PM
Aug-09-23 08:31AM
Aug-08-23 08:31AM
Jul-27-23 08:31AM
Jul-26-23 08:31AM
Jul-21-23 07:04AM
Jun-08-23 08:31AM
May-30-23 08:00AM
May-25-23 08:31AM
May-18-23 08:31AM
May-11-23 04:01PM
May-03-23 08:31AM
Mar-20-23 03:05AM
04:01PM Loading…
Mar-16-23 04:01PM
Mar-14-23 08:31AM
Mar-08-23 08:31AM
Mar-07-23 07:15AM
Mar-02-23 08:31AM
Jan-24-23 08:31AM
Jan-12-23 08:05AM
Jan-05-23 08:31AM
Dec-29-22 08:31AM
Dec-07-22 08:31AM
Nov-16-22 10:17AM
08:45AM
Nov-10-22 04:01PM
Oct-25-22 08:31AM
Oct-13-22 08:31AM
Oct-11-22 08:31AM
Oct-06-22 08:31AM
Sep-29-22 08:31AM
Sep-28-22 08:31AM
06:16AM
Sep-20-22 08:31AM
Sep-15-22 03:47PM
08:31AM
Sep-12-22 08:31AM
Aug-16-22 08:42AM
Aug-11-22 04:01PM
Aug-04-22 08:45AM
Jul-28-22 08:31AM
Jul-26-22 08:31AM
Jul-21-22 09:30AM
Jun-30-22 08:31AM
May-25-22 08:31AM
May-18-22 08:31AM
May-12-22 04:01PM
Apr-28-22 08:31AM
Apr-19-22 04:01PM
Mar-24-22 04:01PM
Mar-10-22 08:31AM
Mar-07-22 08:31AM
Mar-02-22 08:31AM
Feb-11-22 05:05AM
Feb-02-22 05:21PM
Jan-27-22 09:42AM
Jan-11-22 04:19PM
Dec-29-21 08:31AM
Dec-22-21 08:31AM
Dec-16-21 04:01PM
Nov-17-21 08:31AM
Nov-10-21 10:10PM
Feb-02-21 06:50PM
Jan-25-21 01:30PM
Jan-08-21 12:13AM
Jan-07-21 01:55PM
10:09AM
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
de Urioste GeorgeDirectorSep 29 '23Sale2.065,50011,33036,129Oct 03 07:18 PM
de Urioste GeorgeDirectorSep 28 '23Sale2.048,00016,32041,629Sep 29 07:41 PM
de Urioste GeorgeDirectorSep 27 '23Sale2.111,8343,87049,629Sep 29 07:41 PM
de Urioste GeorgeDirectorSep 26 '23Sale2.095,00010,45051,463Sep 27 12:01 PM
de Urioste GeorgeDirectorSep 22 '23Sale2.212,3935,28956,463Sep 27 12:01 PM
de Urioste GeorgeDirectorSep 21 '23Sale2.4110024158,856Sep 22 07:07 PM
de Urioste GeorgeDirectorSep 20 '23Sale2.468832,17258,956Sep 22 07:07 PM
de Urioste GeorgeDirectorSep 18 '23Sale2.465,00012,30059,839Sep 19 06:51 PM
de Urioste GeorgeDirectorSep 15 '23Sale2.434,26910,37464,839Sep 19 06:51 PM
de Urioste GeorgeDirectorSep 14 '23Sale2.175,00010,85069,108Sep 15 05:36 PM
de Urioste GeorgeDirectorSep 13 '23Sale1.935,0009,65674,108Sep 15 05:36 PM
Last Close
Mar 28 02:14PM ET
23.16
Dollar change
+0.21
Percentage change
0.92
%
SAR Saratoga Investment Corp. monthly Stock Chart
Index- P/E11.96 EPS (ttm)1.94 Insider Own6.00% Shs Outstand13.65M Perf Week0.70%
Market Cap316.21M Forward P/E6.38 EPS next Y3.63 Insider Trans0.00% Shs Float11.52M Perf Month-1.86%
Income22.80M PEG- EPS next Q0.95 Inst Own20.30% Short Float0.41% Perf Quarter-10.51%
Sales138.80M P/S2.28 EPS this Y-48.30% Inst Trans-3.62% Short Ratio0.45 Perf Half Y-9.57%
Book/sh27.55 P/B0.84 EPS next Y180.88% ROA2.00% Short Interest0.05M Perf Year-4.46%
Cash/sh3.44 P/C6.73 EPS next 5Y- ROE6.50% 52W Range22.35 - 28.87 Perf YTD-10.44%
Dividend Est.- P/FCF- EPS past 5Y-6.80% ROI3.00% 52W High-19.78% Beta1.34
Dividend TTM2.86 (12.35%) Quick Ratio- Sales past 5Y20.70% Gross Margin44.60% 52W Low3.62% ATR (14)0.29
Dividend Ex-DateMar 12, 2024 Current Ratio- EPS Y/Y TTM- Oper. Margin38.30% RSI (14)50.05 Volatility0.98% 1.12%
Employees- Debt/Eq2.26 Sales Y/Y TTM- Profit Margin16.40% Recom2.10 Target Price26.04
Option/ShortYes / Yes LT Debt/Eq2.26 EPS Q/Q-161.40% Payout145.60% Rel Volume0.86 Prev Close22.95
Sales Surprise1.26% EPS Surprise-2.25% Sales Q/Q38.00% EarningsJan 09 AMC Avg Volume105.37K Price23.16
SMA20-0.05% SMA50-0.27% SMA200-7.62% Trades Volume67,392 Change0.92%
Date Action Analyst Rating Change Price Target Change
Jan-10-24Downgrade Compass Point Buy → Neutral
Jan-08-24Downgrade B. Riley Securities Buy → Neutral $28
Oct-11-23Downgrade Hovde Group Outperform → Market Perform $27
Jul-12-23Downgrade Raymond James Outperform → Mkt Perform
Apr-24-23Initiated Janney Buy $27
Dec-13-22Resumed B. Riley Securities Buy $27.50
Jun-22-21Initiated Raymond James Outperform $30
Jun-16-21Initiated Oppenheimer Outperform $29
Mar-05-21Initiated Hovde Group Outperform $29
Jan-07-21Upgrade Janney Neutral → Buy
Feb-15-24 08:30AM
Jan-11-24 09:19AM
01:22AM
Jan-09-24 10:48PM
09:52PM
04:20PM Loading…
04:20PM
04:05PM
Dec-28-23 08:30AM
Nov-15-23 08:30AM
Oct-13-23 09:55AM
Oct-11-23 09:36AM
Oct-10-23 11:58PM
06:43AM
Oct-09-23 05:15PM
04:13PM
04:05PM Loading…
04:05PM
Sep-27-23 10:40AM
Sep-18-23 05:50PM
Sep-13-23 07:14AM
Aug-15-23 04:05PM
Jul-20-23 05:14AM
Jul-14-23 12:41AM
Jul-12-23 06:37AM
04:28AM
Jul-10-23 05:25PM
04:17PM
04:08PM
Jun-26-23 08:30AM
Jun-01-23 06:12AM
May-22-23 08:30AM
05:36AM Loading…
May-08-23 05:36AM
May-04-23 03:36AM
May-02-23 06:05PM
05:05PM
04:05PM
Apr-28-23 12:10PM
Apr-26-23 10:02AM
Apr-25-23 10:01AM
Apr-18-23 08:30AM
Apr-11-23 05:26PM
08:09AM
Mar-09-23 05:15AM
Mar-08-23 08:16AM
Mar-03-23 05:03AM
Mar-01-23 01:47AM
Feb-28-23 08:30AM
Jan-17-23 12:20PM
Jan-13-23 02:44PM
Jan-12-23 12:29PM
10:30AM
Jan-10-23 05:25PM
04:05PM
Jan-03-23 10:00AM
09:41AM
Dec-21-22 08:30AM
Dec-09-22 12:00PM
Dec-05-22 05:31PM
07:57AM
Nov-22-22 04:36AM
Nov-15-22 08:30AM
Nov-01-22 12:20PM
Oct-25-22 09:55AM
Oct-19-22 05:32PM
08:08AM
Oct-04-22 05:25PM
04:05PM
Oct-03-22 08:30AM
Sep-29-22 08:30AM
Sep-20-22 08:30AM
Sep-08-22 05:55PM
Sep-06-22 06:15PM
Sep-01-22 09:53AM
Aug-29-22 08:30AM
Aug-16-22 09:00AM
Jul-27-22 10:10AM
Jul-07-22 04:00PM
Jul-06-22 05:27PM
04:05PM
Jun-23-22 08:30AM
Jun-08-22 05:35PM
May-26-22 06:50AM
May-25-22 06:54AM
May-10-22 04:31PM
May-06-22 12:30AM
May-04-22 07:45PM
04:05PM
Apr-28-22 05:45PM
Apr-21-22 04:05PM
Apr-19-22 05:30PM
Apr-18-22 05:05PM
Feb-24-22 08:30AM
Feb-17-22 01:30PM
Jan-19-22 04:05PM
Jan-13-22 04:42PM
Jan-07-22 11:26AM
Jan-06-22 10:00PM
Jan-05-22 05:25PM
04:05PM
Dec-29-21 03:00PM
Dec-23-21 01:36PM
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. was formed on 2007 and is based in New York, New York with an additional office in Florham Park, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oberbeck Christian LCEO, Director and PresidentMay 04 '23Buy23.812,00047,620689,775May 08 02:54 PM
Last Close
Mar 28 02:14PM ET
28.48
Dollar change
-0.02
Percentage change
-0.09
%
DYN Dyne Therapeutics Inc monthly Stock Chart
IndexRUT P/E- EPS (ttm)-3.94 Insider Own38.44% Shs Outstand61.47M Perf Week-2.42%
Market Cap2.31B Forward P/E- EPS next Y-3.00 Insider Trans-9.62% Shs Float49.93M Perf Month13.99%
Income-235.94M PEG- EPS next Q-0.79 Inst Own52.80% Short Float13.66% Perf Quarter108.76%
Sales0.00M P/S- EPS this Y16.12% Inst Trans-3.35% Short Ratio3.01 Perf Half Y231.10%
Book/sh1.49 P/B19.17 EPS next Y9.39% ROA-100.10% Short Interest6.82M Perf Year155.84%
Cash/sh1.52 P/C18.76 EPS next 5Y- ROE-137.31% 52W Range6.40 - 30.27 Perf YTD114.10%
Dividend Est.- P/FCF- EPS past 5Y-106.26% ROI-206.99% 52W High-5.93% Beta0.95
Dividend TTM- Quick Ratio2.53 Sales past 5Y0.00% Gross Margin- 52W Low344.92% ATR (14)1.99
Dividend Ex-Date- Current Ratio2.53 EPS Y/Y TTM-21.58% Oper. Margin0.00% RSI (14)58.48 Volatility8.72% 8.02%
Employees141 Debt/Eq0.30 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price37.56
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q-46.68% Payout- Rel Volume0.27 Prev Close28.50
Sales Surprise- EPS Surprise-18.90% Sales Q/Q- EarningsMar 05 BMO Avg Volume2.26M Price28.48
SMA204.77% SMA5020.45% SMA200103.06% Trades Volume455,001 Change-0.09%
Date Action Analyst Rating Change Price Target Change
Feb-20-24Initiated H.C. Wainwright Buy $36
Feb-27-23Upgrade Raymond James Outperform → Strong Buy $16 → $27
Feb-15-23Initiated Oppenheimer Outperform $34
Jan-26-23Initiated Guggenheim Buy $33
Jul-20-22Initiated Chardan Capital Markets Buy $17
Jul-12-22Initiated Raymond James Outperform $15
Oct-12-20Initiated Stifel Buy $29
Oct-12-20Initiated Piper Sandler Overweight $34
Oct-12-20Initiated JP Morgan Overweight $27
Oct-12-20Initiated Jefferies Buy $47
Mar-27-24 04:05PM
08:30AM
Mar-25-24 12:28PM
07:30AM
Mar-13-24 07:30AM
01:19PM Loading…
Mar-07-24 01:19PM
Mar-05-24 10:53AM
07:30AM
Mar-02-24 12:00AM
Feb-29-24 03:02AM
Feb-14-24 04:15PM
Feb-01-24 07:30AM
Jan-26-24 11:01PM
Jan-22-24 10:14PM
Jan-12-24 01:12PM
04:05PM Loading…
Jan-11-24 04:05PM
Jan-05-24 09:02AM
07:30AM
Jan-04-24 10:46PM
04:37PM
12:39PM
Jan-03-24 04:25PM
02:46PM
02:01PM
08:19AM
06:30AM
Jan-02-24 04:05PM
Nov-13-23 06:59PM
Nov-07-23 07:30AM
Oct-31-23 05:36AM
01:11AM Loading…
01:11AM
Oct-30-23 07:30AM
Sep-28-23 07:30AM
Sep-20-23 04:05PM
Sep-15-23 01:52PM
Sep-14-23 01:22PM
Sep-05-23 07:30AM
Aug-28-23 10:22AM
Aug-03-23 07:30AM
Jun-16-23 08:46AM
Jun-01-23 07:30AM
May-25-23 07:30AM
May-17-23 11:25AM
07:30AM
May-11-23 07:30AM
May-03-23 07:35AM
May-02-23 04:46PM
Mar-23-23 07:30AM
Mar-20-23 07:30AM
Mar-07-23 07:30AM
Mar-02-23 07:30AM
Mar-01-23 09:00AM
Feb-27-23 04:40PM
Feb-05-23 05:03AM
Jan-19-23 08:23AM
Jan-18-23 08:49AM
Jan-10-23 12:00PM
Jan-03-23 07:30AM
Dec-16-22 09:55AM
Dec-09-22 09:55AM
Dec-08-22 08:10AM
Nov-30-22 09:55AM
Nov-03-22 07:30AM
Nov-02-22 07:30AM
Oct-31-22 07:30AM
Oct-12-22 06:45AM
Oct-11-22 04:10PM
Sep-27-22 07:30AM
Sep-12-22 07:00AM
Sep-06-22 04:30PM
07:01AM
07:00AM
Aug-29-22 07:30AM
Aug-10-22 07:30AM
Aug-04-22 07:30AM
Jul-18-22 10:00AM
Jul-12-22 02:54PM
07:30AM
Jul-05-22 07:30AM
Jul-01-22 06:58AM
Jun-03-22 07:30AM
May-16-22 07:30AM
May-02-22 04:05PM
Mar-17-22 08:45AM
Mar-10-22 07:30AM
Mar-03-22 07:30AM
Feb-02-22 01:38PM
Jan-22-22 08:06AM
Jan-18-22 04:18PM
08:00AM
Jan-05-22 07:30AM
Dec-03-21 03:30PM
Dec-02-21 08:30AM
Nov-04-21 07:30AM
Oct-26-21 10:41AM
Oct-13-21 07:45AM
Oct-01-21 10:21AM
07:30AM
Sep-28-21 07:30AM
Sep-27-21 07:30AM
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farwell WildonChief Medical OfficerMar 12 '24Sale25.581,03026,347150,560Mar 12 09:58 PM
Brumm Joshua TCEO & PresidentMar 11 '24Option Exercise5.5450,000277,000604,385Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 11 '24Option Exercise5.5417,82598,750159,009Mar 13 06:04 AM
Brumm Joshua TCEO & PresidentMar 11 '24Sale25.6766,3871,704,142537,998Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 11 '24Sale25.5019,601499,842139,408Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 11 '24Sale25.282,67267,542119,283Mar 12 09:57 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 11 '24Sale25.702,29258,904156,800Mar 13 06:04 AM
Beskrovnaya OxanaChief Scientific OfficerMar 11 '24Sale25.702,08153,482152,352Mar 12 09:42 PM
Farwell WildonChief Medical OfficerMar 11 '24Sale25.701,58540,734151,590Mar 12 09:58 PM
Brumm Joshua TCEO & PresidentMar 08 '24Option Exercise5.54363,3432,012,920917,728Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 08 '24Option Exercise5.5490,000498,600231,184Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08 '24Option Exercise5.5486,252477,836208,207Mar 12 09:57 PM
Brumm Joshua TCEO & PresidentMar 08 '24Sale25.93363,3439,421,634554,385Mar 12 09:56 PM
McNeill JonathanChief Business OfficerMar 08 '24Sale26.2490,0002,361,531141,184Mar 13 06:04 AM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08 '24Sale26.2286,2522,261,465121,955Mar 12 09:57 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 08 '24Sale26.6727,199725,344159,092Mar 13 06:04 AM
Farwell WildonChief Medical OfficerMar 07 '24Sale25.869,921256,585153,175Mar 11 09:52 PM
Brumm Joshua TCEO & PresidentMar 07 '24Sale25.859,086234,873554,385Mar 11 09:57 PM
McNeill JonathanChief Business OfficerMar 07 '24Sale25.852,43462,919141,184Mar 11 09:50 PM
Beskrovnaya OxanaChief Scientific OfficerMar 07 '24Sale25.852,37361,342154,433Mar 11 09:56 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 07 '24Sale25.852,27358,757121,955Mar 11 09:45 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 07 '24Sale25.851,59141,127186,291Mar 11 09:56 PM
Brumm Joshua TCEO & PresidentMar 01 '24Option Exercise5.5494,480523,419657,951Mar 01 09:38 PM
McNeill JonathanChief Business OfficerMar 01 '24Option Exercise0.7324,26017,710167,878Mar 01 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01 '24Option Exercise1.039,3119,590133,539Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentMar 01 '24Sale29.0494,4802,743,718563,471Mar 01 09:38 PM
Rhodes Jason PDirectorMar 01 '24Sale30.0546,5341,398,347847,388Mar 05 05:08 PM
Atlas Venture Opportunity Fund10% OwnerMar 01 '24Sale30.0529,435884,5221,458,691Mar 05 05:07 PM
McNeill JonathanChief Business OfficerMar 01 '24Sale28.6324,260694,495143,618Mar 01 09:37 PM
Atlas Venture Opportunity Fund10% OwnerMar 01 '24Sale30.0517,099513,825847,388Mar 05 05:07 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01 '24Sale28.259,311262,999124,228Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentFeb 29 '24Option Exercise5.545,52030,581568,991Mar 01 09:38 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29 '24Option Exercise1.033,4293,532127,657Mar 01 09:37 PM
McNeill JonathanChief Business OfficerFeb 29 '24Option Exercise0.734,2683,116147,886Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentFeb 29 '24Sale27.505,520151,800563,471Mar 01 09:38 PM
McNeill JonathanChief Business OfficerFeb 29 '24Sale27.504,268117,370143,618Mar 01 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29 '24Sale27.503,42994,298124,228Mar 01 09:37 PM
Rhodes Jason PDirectorFeb 28 '24Sale24.84190,9204,741,804864,487Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28 '24Sale24.84154,6743,841,5765,698,091Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 28 '24Sale24.8436,246900,228864,487Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 27 '24Sale24.41368,6998,998,426877,806Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27 '24Sale24.41298,7027,290,0885,852,765Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 27 '24Sale24.4169,9971,708,338877,806Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 26 '24Sale23.72248,2195,886,673903,527Feb 28 07:15 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26 '24Sale23.72201,0954,769,0966,151,467Feb 28 07:13 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 26 '24Sale23.7247,1241,117,577903,527Feb 28 07:13 PM
Rhodes Jason PDirectorFeb 23 '24Sale22.70196,9284,470,266920,843Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23 '24Sale22.70159,5423,621,6036,352,562Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 23 '24Sale22.7037,386848,662920,843Feb 23 06:58 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 22 '24Sale22.66119,3602,704,6986,512,104Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 22 '24Sale22.66119,3602,704,6986,512,104Feb 23 06:59 PM
Rhodes Jason PDirectorFeb 21 '24Sale22.57184,5014,164,8176,631,464Feb 23 06:59 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 21 '24Sale22.57184,5014,164,8176,631,464Feb 23 06:58 PM
Rhodes Jason PDirectorFeb 20 '24Sale22.72169,5393,852,6536,815,965Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 20 '24Sale22.72169,5393,852,6536,815,965Feb 20 06:35 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 16 '24Sale23.14162,7073,765,0406,985,504Feb 20 06:35 PM
Rhodes Jason PDirectorFeb 16 '24Sale23.14162,7073,765,0406,985,504Feb 20 06:36 PM
Rhodes Jason PDirectorFeb 15 '24Sale23.89177,9064,249,6007,148,211Feb 20 06:36 PM
Atlas Venture Fund XI, L.P.10% OwnerFeb 15 '24Sale23.89177,9064,249,6007,148,211Feb 20 06:35 PM
Farwell WildonChief Medical OfficerFeb 12 '24Sale25.075,493137,710163,503Feb 14 04:27 PM
McNeill JonathanChief Business OfficerJan 26 '24Option Exercise0.7320,00014,600163,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26 '24Option Exercise1.0313,00013,390137,228Jan 26 07:47 PM
McNeill JonathanChief Business OfficerJan 26 '24Sale24.5320,000490,510143,618Jan 26 07:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26 '24Sale24.3413,000316,420124,228Jan 26 07:47 PM
Farwell WildonChief Medical OfficerJan 26 '24Sale25.001002,500168,996Jan 26 07:49 PM
Kersten DirkDirectorJan 09 '24Buy17.501,714,28529,999,9886,416,793Jan 11 04:31 PM
Brumm Joshua TCEO & PresidentJan 04 '24Option Exercise5.16218,5361,127,092803,507Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04 '24Option Exercise1.0322,67423,354199,259Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04 '24Option Exercise0.732,0091,467145,627Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 04 '24Sale18.51218,5364,045,958584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 04 '24Sale18.1342,453769,673156,806Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 04 '24Sale18.042,00936,242143,618Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03 '24Option Exercise1.0351,18352,718636,154Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03 '24Option Exercise1.0345,32646,686221,911Jan 04 09:48 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03 '24Option Exercise1.0313,00013,390137,228Jan 04 09:46 PM
McNeill JonathanChief Business OfficerJan 03 '24Option Exercise0.7317,99113,133161,609Jan 04 09:47 PM
Brumm Joshua TCEO & PresidentJan 03 '24Sale19.2851,183986,957584,971Jan 04 09:49 PM
Beskrovnaya OxanaChief Scientific OfficerJan 03 '24Sale18.9845,326860,313176,585Jan 04 09:48 PM
McNeill JonathanChief Business OfficerJan 03 '24Sale18.7417,991337,062143,618Jan 04 09:47 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03 '24Sale18.8113,000244,530124,228Jan 04 09:46 PM
McNeill JonathanChief Business OfficerJan 02 '24Sale13.1011,900155,890143,618Jan 04 09:47 PM
Scalzo Richard WilliamSee RemarksDec 14 '23Sale12.022,37628,560124,228Dec 14 04:59 PM
Farwell WildonChief Medical OfficerDec 12 '23Sale10.5597810,318169,096Dec 12 05:33 PM
Brumm Joshua TSee RemarksDec 11 '23Sale10.727,58581,311584,971Dec 12 05:33 PM
Farwell WildonChief Medical OfficerDec 11 '23Sale10.721,68818,095170,074Dec 12 05:33 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 11 '23Sale10.721,61617,324187,882Dec 12 05:34 PM
Beskrovnaya OxanaChief Scientific OfficerDec 11 '23Sale10.721,46715,726176,585Dec 12 05:32 PM
Scalzo Richard WilliamSee RemarksDec 11 '23Sale10.721,38014,794126,604Dec 12 05:35 PM
McNeill JonathanChief Business OfficerDec 11 '23Sale10.721,24513,346155,518Dec 12 05:34 PM
Scalzo Richard WilliamSee RemarksDec 06 '23Sale12.011,87222,483127,984Dec 06 06:13 PM
Scalzo Richard WilliamSee RemarksDec 04 '23Sale12.016818,179129,856Dec 06 06:13 PM
HIGH SUSANNA GATTIChief Operating OfficerNov 02 '23Sale7.409,93973,54994,605Nov 02 05:16 PM
Brumm Joshua TSee RemarksSep 18 '23Sale9.4112,032113,221233,679Sep 20 04:47 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 18 '23Sale9.412,67225,144104,544Sep 20 04:48 PM
Beskrovnaya OxanaChief Scientific OfficerSep 18 '23Sale9.411,43613,51384,334Sep 20 04:47 PM
Scalzo Richard WilliamSee RemarksSep 18 '23Sale9.411,29012,13940,795Sep 20 04:49 PM
McNeill JonathanChief Business OfficerSep 18 '23Sale9.411,26111,86660,605Sep 20 04:49 PM
Brumm Joshua TSee RemarksSep 12 '23Sale10.417,67279,866245,711Sep 13 07:50 PM
Farwell WildonChief Medical OfficerSep 12 '23Sale10.411,70717,77089,250Sep 13 07:56 PM
HIGH SUSANNA GATTIChief Operating OfficerSep 12 '23Sale10.411,63517,020107,216Sep 13 07:51 PM